
GC33206
ERK-IN-1
Also known as 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide
ERK-IN-1 (compound B) is an orally available ERK1 and ERK2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway· The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer· ERK-IN-1 hydrochloride can also inhibit RAF
- CAS number
- 1715025-32-3
- Molecular weight
- 578.42
- Formula
- C26H27BrF3N5O2
- Solubility
- Soluble in DMSO
- InChIKey
- YFCIFWOJYYFDQP-PTWZRHHISA-N
- Catalogue number
- GC33206
- Brand
- GLPBIO
Computed properties PubChem CID 118045847 · XLogP 3.1 · TPSA 113 Ų · H-bond donors 4
- XLogP
- 3.1
- TPSA
- 113 Ų
- H-bond donors
- 4
- H-bond acceptors
- 9
- Rotatable bonds
- 7
- Heavy atoms
- 37
SMILES CNC[C@H](C1=CC(=CC(=C1)Br)F)NC(=O)C2=C(C=C(C=C2)C3=NC(=CN=C3N)[C@H]4CC[C@@H]([C@H](C4)F)O)F
Computed descriptors from PubChem (CID 118045847), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il